Literature DB >> 26776227

NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure.

Tobias B Halene1, Alexey Kozlenkov2, Yan Jiang2, Amanda C Mitchell2, Behnam Javidfar2, Aslihan Dincer2, Royce Park2, Jennifer Wiseman2, Paula L Croxson3, Eustathia Lela Giannaris4, Patrick R Hof3, Panos Roussos5, Stella Dracheva2, Scott E Hemby6, Schahram Akbarian2.   

Abstract

Increased neuronal densities in subcortical white matter have been reported for some cases with schizophrenia. The underlying cellular and molecular mechanisms remain unresolved. We exposed 26 young adult macaque monkeys for 6 months to either clozapine, haloperidol or placebo and measured by structural MRI frontal gray and white matter volumes before and after treatment, followed by observer-independent, flow-cytometry-based quantification of neuronal and non-neuronal nuclei and molecular fingerprinting of cell-type specific transcripts. After clozapine exposure, the proportion of nuclei expressing the neuronal marker NeuN increased by approximately 50% in subcortical white matter, in conjunction with a more subtle and non-significant increase in overlying gray matter. Numbers and proportions of nuclei expressing the oligodendrocyte lineage marker, OLIG2, and cell-type specific RNA expression patterns, were maintained after antipsychotic drug exposure. Frontal lobe gray and white matter volumes remained indistinguishable between antipsychotic-drug-exposed and control groups. Chronic clozapine exposure increases the proportion of NeuN+ nuclei in frontal subcortical white matter, without alterations in frontal lobe volumes or cell type-specific gene expression. Further exploration of neurochemical plasticity in non-human primate brain exposed to antipsychotic drugs is warranted.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotic; Clozapine; Flow cytometry; Monkey; Schizophrenia; White matter

Mesh:

Substances:

Year:  2016        PMID: 26776227      PMCID: PMC4740223          DOI: 10.1016/j.schres.2015.12.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  77 in total

1.  Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.

Authors:  S Akbarian; A Viñuela; J J Kim; S G Potkin; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1993-03

2.  A novel flow cytometry-based technique to measure adult neurogenesis in the brain.

Authors:  Robert Spoelgen; Annette Meyer; Anja Moraru; Friederike Kirsch; Angela Vogt-Eisele; Christian Plaas; Claudia Pitzer; Armin Schneider
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

3.  Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Authors:  Mohamed Ahmed; Dara M Cannon; Cathy Scanlon; Laurena Holleran; Heike Schmidt; John McFarland; Camilla Langan; Peter McCarthy; Gareth J Barker; Brian Hallahan; Colm McDonald
Journal:  Neuropsychopharmacology       Date:  2015-04-01       Impact factor: 7.853

4.  Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients.

Authors:  S Akbarian; J J Kim; S G Potkin; W P Hetrick; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1996-05

5.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.

Authors:  M S Lidow; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder.

Authors:  Clare L Beasley; Mrinalini Honavar; Ian P Everall; David Cotter
Journal:  Schizophr Res       Date:  2009-12       Impact factor: 4.939

7.  Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis.

Authors:  S L Eastwood; P J Harrison
Journal:  Mol Psychiatry       Date:  2003-09       Impact factor: 15.992

8.  Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex.

Authors:  Dan Ma; Man K Chan; Helen E Lockstone; Sandra R Pietsch; Declan N C Jones; Jackie Cilia; Mark D Hill; Melanie J Robbins; Isabel M Benzel; Yagnesh Umrania; Paul C Guest; Yishai Levin; Peter R Maycox; Sabine Bahn
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

Review 9.  Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.

Authors:  Massimo C Mauri; Lucia S Volonteri; Alessandro Colasanti; Alessio Fiorentini; Ilaria F De Gaspari; Silvio R Bareggi
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

10.  Antipsychotic-induced gene regulation in multiple brain regions.

Authors:  Matthew James Girgenti; Laura K Nisenbaum; Franklin Bymaster; Rosemarie Terwilliger; Ronald S Duman; Samuel Sathyanesan Newton
Journal:  J Neurochem       Date:  2010-01-13       Impact factor: 5.372

View more
  7 in total

1.  Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.

Authors:  M Feher; B Gaszner; A Tamas; A L Gil-Martinez; E Fernandez-Villalba; M T Herrero; D Reglodi
Journal:  Neurotox Res       Date:  2017-12-11       Impact factor: 3.911

2.  High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy.

Authors:  Balagopal Pai; Jessica Tome-Garcia; Wan Sze Cheng; German Nudelman; Kristin G Beaumont; Saadi Ghatan; Fedor Panov; Elodia Caballero; Kwadwo Sarpong; Lara Marcuse; Jiyeoun Yoo; Yan Jiang; Anne Schaefer; Schahram Akbarian; Robert Sebra; Dalila Pinto; Elena Zaslavsky; Nadejda M Tsankova
Journal:  Acta Neuropathol Commun       Date:  2022-10-23       Impact factor: 7.578

3.  Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons.

Authors:  Taixiang Saur; Bruce M Cohen; Qi Ma; Suzann M Babb; Edgar A Buttner; Wei-Dong Yao
Journal:  J Neurogenet       Date:  2016-09-14       Impact factor: 1.250

4.  Clozapine As Transformative Treatment In Bipolar Patients.

Authors:  Alina Wilkowska; Wiesław J Cubała
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-09       Impact factor: 2.570

5.  Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia.

Authors:  Fanni Krajner; Laila Hadaya; Grant McQueen; Kyra-Verena Sendt; Amy Gillespie; Alessia Avila; John Lally; Emily P Hedges; Kelly Diederen; Oliver D Howes; Gareth J Barker; David J Lythgoe; Matthew J Kempton; Philip McGuire; James H MacCabe; Alice Egerton
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-02

6.  Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.

Authors:  Benxia Hu; Hyejung Won; Won Mah; Royce B Park; Bibi Kassim; Keeley Spiess; Alexey Kozlenkov; Cheynna A Crowley; Sirisha Pochareddy; Yun Li; Stella Dracheva; Nenad Sestan; Schahram Akbarian; Daniel H Geschwind
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 17.694

Review 7.  Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope?

Authors:  Federico E Turkheimer; Pierluigi Selvaggi; Mitul A Mehta; Mattia Veronese; Fernando Zelaya; Paola Dazzan; Anthony C Vernon
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 7.348

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.